# A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

> **NCT04151212** · PHASE1 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 24 (actual)

## Conditions studied

- Age-related Macular Degeneration

## Interventions

- **DRUG:** BAT5906 injection

## Key facts

- **NCT ID:** NCT04151212
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-04-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04151212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04151212, "A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04151212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*